OPKO Health (NASDAQ: OPK) reported Q1 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $124.2 million versus the consensus estimate of $130.8 million.

GUIDANCE:

OPKO Health sees Q2 2026 revenue of $127-132 million, versus the consensus of $135.6 million.

OPKO Health sees FY2026 revenue of $530-560 million, versus the consensus of $545.6 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.